(Q84406085)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692048%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Survival after complete surgical resection of multiple metastases from renal cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692048%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

Angela L Alt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692048%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Stephen A Boorjian

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692048%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Christine M Lohse

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692048%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Brian A Costello

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692048%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Bradley C Leibovich

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692048%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Michael L Blute

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692048%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

10 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692048%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692048%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692048%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692048%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

2873-2882

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692048%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

The changing natural history of renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

A POSTOPERATIVE PROGNOSTIC NOMOGRAM PREDICTING RECURRENCE FOR PATIENTS WITH CONVENTIONAL CLEAR CELL RENAL CELL CARCINOMA

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Risk score and metastasectomy independently impact prognosis of patients with recurrent renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Resection of metastatic renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Surgeon's role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: an institutional review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Prospective assessment of systemic therapy followed by surgical removal of metastases in selected patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

No role of adjuvant systemic therapy after complete metastasectomy in metastatic renal cell carcinoma?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Long-term results after pulmonary resection of renal cell carcinoma metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

The role of surgery in the management of isolated metastases to the pancreas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Can we predict long-term survival after pulmonary metastasectomy for renal cell carcinoma?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Pulmonary resection of metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Metastatic renal cell carcinoma of bone: indications and technique of surgical intervention

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Patient survival after surgery for osseous metastases from renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Hepatic resection for metastatic renal tumors: is it worthwhile?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Surgical resection of brain metastases from renal cell carcinoma in 50 patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Outcome of surgical treatment of isolated local recurrence after radical nephrectomy for renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Management of isolated renal fossa recurrence following radical nephrectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Cytoreductive nephrectomy and nephrectomy/complete metastasectomy for metastatic renal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Aggressive treatment of metastatic renal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Histologic predictors of renal cell carcinoma response to interleukin-2-based therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Renal Cell Carcinoma Recurrence After Nephrectomy for Localized Disease: Predicting Survival From Time of Recurrence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Surgical resection of renal cell carcinoma after targeted therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25836

7 January 2021

Identifiers

DOI

10.1002/CNCR.25836

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692048%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference